Cipro buyers oppose summary judgment in class action over $398.1 million reverse-payment
MLex Summary: Bayer paid $398.1 million to avoid the risk of the introduction of a generic version of the antibiotic Cipro, a payment that was clearly intended to avoid competiton in...To view the full article, register now.
Already a subscriber? Click here to view full article